M/19/042 - Portlon (Parma)/Galway Clinic [2020] IECompA m19042 (24 April 2020)

M/19/042 - Portlon (Parma)/Galway Clinic [2020] IECompA m19042 (24 April 2020)

The Competition and Consumer Protection Commission found that the proposed acquisition would not substantially lessen competition in the private healthcare sector and therefore cleared the transaction.

Parties
Acquirer: Parma Investments Limited; Target: Marpole Limited; Receiver: Ken Fennell of Deloitte
Jurisdiction
Ireland
Judgment Date
24 April 2020
Procedural Posture
Merger Clearance / Phase 1 Determination
Outcome
cleared
Legal Topics
Merger Control, Acquisition of Shareholding, Private Healthcare Sector
Competition Law Merger Control Acquisition of Shareholding Private Healthcare Sector

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Parma Investments Limited

Acquirer

Marpole Limited

Target

Ken Fennell of Deloitte

Receiver

Procedural Posture

Merger Clearance / Phase 1 Determination

Legal Issues

  1. 1 Whether the proposed acquisition of 25% shareholding in Marpole Limited by Parma Investments Limited raises competition concerns in the private healthcare sector.

Ratio Decidendi

The Competition and Consumer Protection Commission found that the proposed acquisition would not substantially lessen competition in the private healthcare sector and therefore cleared the transaction.

Court Disposition

cleared

Orders

  • The proposed acquisition by Parma Investments Limited of 25% shareholding in Marpole Limited is cleared.